HOME >> BIOLOGY >> NEWS
Most clones doomed from the start, according to Temple University embryologist

Until scientists can improve the early development of cloned embryos, cloning will remain marginally successful, according to research presented today at the American Association for the Advancement of Science (AAAS). Currently, only 1-5 percent of cloned embryos succeed, and many that do succeed are unhealthy.

Keith Latham, Ph.D., Associate Professor of Biochemistry at Temple University School of Medicine, presented the research during the symposium, "Cloning Controversies: Ethics, Science and Society." Latham's presentation, "Somatic Cell-Like Features of Cloned Embryos," highlighted the differences that persist between a normal embryo and a cloned embryo and stand in the way of cloning success.

Contributing to the poor success is the inefficiency and slow rate of reprogramming. Reprogramming is the process whereby cloned embryo genes are turned off and normal embryo genes are turned on, allowing a cloned embryo to develop normally. For some reason, most cloned embryos are unable to make this transformation. Consequently, cloned embryos develop and behave as a hybrid somewhere between an embryo and the adult organism from which it has been cloned.

"Until we learn how to improve the reprogramming of cloned embryos and how to help them transition into a normal, healthy embryo, cloning will remain marginally successful," said Latham.

Latham's research portfolio is focused on reproduction and development at the molecular level. He is currently running four major research projects, all funded by the National Institutes of Health.


'"/>

Contact: Eryn Jelesiewicz
eryn.jelesiewicz@temple.edu
215-707-0730
Temple University
16-Feb-2004


Page: 1

Related biology news :

1. Advance warning of storms and cyclones with new technique
2. Texas A&M clones first cat
3. New study shows normal-looking clones may be abnormal
4. The silence of the clones: new link between DNA replication and silent chromosome architecture
5. Dyslexics not doomed to life of reading difficulties
6. Portrait of a doomed Sea
7. The future of HIV therapeutics is brightening, according to Gladstone Institutes Director
8. Mitochondria in spinal cords is ALS target according to UCSD medical researchers
9. Espionage may have driven the evolution of bee language according to UCSD-led study in Brazil
10. Chicken litter harbors agents that generate antibiotic multi-resistance, according to UGA study
11. Governing commons still a struggle, but fight not without hope, according to new report

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/18/2020)... ... July 17, 2020 , ... Commercial launch readiness is a critical stage in ... COVID cure or vaccine, the global economic downturn will only increase price pressures overall ... away and capturing full value from every product launch is critical. However, history shows ...
(Date:7/4/2020)... ... , ... Aesthetics Biomedical (ABM), a leading aesthetics product development ... the products and treatments developed, but also the dedicated team behind the brands ... built by ABM have received several honors already for 2020, each of which ...
(Date:7/1/2020)... ... 2020 , ... Catalent, a global leader in clinical supply ... facility in Minakuchi, located in the Shiga prefecture of Japan. , Operating in ... new 60,000-square-foot facility will provide customers with flexible clinical supply solutions, serving both ...
Breaking Biology News(10 mins):
(Date:8/12/2020)... BINGHAM FARMS, Mich. (PRWEB) , ... August 12, ... ... International Consulting Group, Inc. (EMMA International), a global leader in FDA compliance ... ranking of the nation’s fastest-growing private companies. The list represents a unique look ...
(Date:7/31/2020)... , ... July 29, 2020 , ... R3 Stem Cell ... for only $3950. With 50 million stem cells total, patients may choose which extremities ... therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord ...
(Date:7/31/2020)... N.J (PRWEB) , ... July 29, 2020 , ... ... company, and Catalent, the leading global provider of advanced delivery technologies, development, and ... today announced that they have entered into a strategic partnership whereby Catalent will ...
(Date:7/22/2020)... ... July 22, 2020 , ... Join experts from Reed Tech , ... Solutions, in a one hour live webinar on Thursday, August 13, 2020 ... for drugs and medical devices. Specifically, for medical devices, the NMPA has departments dealing ...
Breaking Biology Technology:
Cached News: